Exploring therapeutic approaches against Naegleria fowleri infections through the COVID box

This publication has 47 references indexed in Scilit:

• A Biochemical Comparison of Proteases from Pathogenic Naegleria fowleri and Non‐Pathogenic Naegleria gruberi
  Journal of Eukaryotic Microbiology, 2007
• In‐Vitro Activity of Miltefosine and Voriconazole on Clinical Isolates of Free‐Living Amebas: Balamuthia mandrillaris, Acanthamoeba spp., and Naegleria fowleri
  Journal of Eukaryotic Microbiology, 2006
• Pharmacological Properties of ABT-239 [4-(2-{2-[(2 R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: II. Neurophysiological Characterization and Broad Preclinical Efficacy in Cognition and Schizophrenia of a Potent and Selective Histamine H3 Receptor Antagonist
  The Journal of Pharmacology and Experimental Therapeutics, 2005
• Development of Colorimetric Microtiter Plate Assay for Assessment of Antimicrobials against Acanthamoeba
  Journal of Clinical Microbiology, 2005
• Balamuthia mandrillaris from soil samples
  Microbiology, 2004
• Antihistamines in the Treatment of Atopic Dermatitis
  Journal of Cutaneous Medicine and Surgery, 2003
• Azole fungicides affect mammalian steroidogenesis by inhibiting sterol 14 alpha-demethylase and aromatase.
  Environmental Health Perspectives, 2003
• Naegleria meningitis: a rare survival.
  2002
• Terconazole Cream for Non-Candida albicans Fungal Vaginitis: Results of a Retrospective Analysis
  Infectious Diseases in Obstetrics and Gynecology, 2000
• Neuroimaging findings in rare amebic infections of the central nervous system.
  1995